Debiopharm Is A Swiss Biopharmaceutical Company Founded In 1979 And Headquartered In Lausannewith Additional Operations In Martignythe Company Is Dedicated To Developing Innovative Therapies For Oncology And Infectious Diseasesfocusing On High Unmet Medical Needsdebiopharm Operates By In Licensing Promising Compoundsadvancing Them Through Clinical Developmentand Partnering With Global Pharmaceutical Companies For Commercialization The Company Specializes In Drug Developmentoffering Services That Include Preclinical Researchclinical Trialsand Regulatory Strategydebiopharm Collaborates With Academic Institutionsbiotech Firmsand Pharmaceutical Partners To Facilitate The Transition From Early Stage Discoveries To Global Patient Accessits Key Products Include Triptorelinapproved For Advanced Prostate Cancer And Endometriosisand Oxaliplatina Standard Treatment For Metastatic Colorectal Cancerthe Company Is Also Focused On Developing Targeted Therapies And Immuno Oncology Treatmentsdebiopharm S Mission Is To Establish Tomorrowae S Standard Of Care By Advancing Therapies That Cure Cancercombat Infectious Diseasesand Enhance Patient Quality Of Life
